A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

Aichi Clinical Site 1, Tokoname

Chiba Clinical Site 1, Narita

Fukuoka Clinical Site 1, Ōkawa

Ibaraki Clinical Site 1, Tsuchiura

Ishikawa Clinical Site 1, Kanazawa

Kanagawa Clinical Site 3, Kawasaki

Kanagawa Clinical Site 1, Yokohama

Kanagawa Clinical Site 2, Yokosuka

Mie Clinical Site 1, Yokkaichi

Niigata Clinical Site 1, Nagaoka

Osaka Clinical Site 2, Daitō

Saitama Clinical Site 3, Kawagoe

Saitama Clinical Site 1, Kukichūō

Saitama Clinical Site 2, Kumagaya

Tokyo Clinical Site 5, Bunkyo-ku

Tokyo Clinical Site 9, Bunkyo-ku

Tokyo Clinical Site1, Hachiōji

Tokyo Clinical Site 7, Itabashi-ku

Tokyo Clinical Site 3, Meguro-ku

Tokyo Clinical Site 4, Shinagawa-ku

Tokyo Clinical Site 8, Sibuya-ku

Tokyo Clinical Site2, Sibuya-ku

Tokyo Clinical Site 6, Tachikawa

Okayama Clinical Site 1, Okayama

Osaka Clinical Site 1, Osaka